Joakim Wijkstrom

Senior Vice President, Chief Marketing OfficeratVanda Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+37% from the year before · Vanda Pharmaceuticals stock +84.1% the same year

Joakim Wijkstrom was paid $1.5M in FY2025 (Dec), up 37%. Vanda Pharmaceuticals stock rose 84.1% that year.

Pay$100 in the stock at the end of FY20 → $67

Pay is from the Summary Compensation Table of each Vanda Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

VNDA
Vanda PharmaceuticalsPublic company · 5 yr
- Senior Vice President, Chief Marketing Officer2021 – Present · 5 yrStock in role -70%

Roles come from the proxy statements of each company.

Activity

Pay
Vanda Pharmaceuticals CMO pay rose 37% to $1.5M. The stock rose 84% in FY2025 (Dec).
DEF 14AApr 23, 2026
Pay
Vanda Pharmaceuticals CMO pay fell 22% to $1.1M. The stock rose 14% in FY2024 (Dec).
DEF 14AApr 25, 2025
Pay
Vanda Pharmaceuticals CMO pay fell 16% to $1.4M. The stock fell 43% in FY2023 (Dec).
DEF 14AApr 29, 2024
Pay
Vanda Pharmaceuticals CMO pay fell 13% to $1.6M. The stock fell 53% in FY2022 (Dec).
DEF 14AApr 29, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?